The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
AVAstrid van Hylckama VliegFMFrans M. HelmerhorstJPJan P. VandenbrouckeCJCarine J.M. DoggenFRFrits R. Rosendaal
Leiden University Medical Center
Indexed incrossrefpubmed
Abstract
Objective
To assess the thrombotic risk associated with oral contraceptive use with a focus on dose of oestrogen and type of progestogen of oral contraceptives available in the Netherlands.
Design
Population based case-control study.
Setting
Six participating anticoagulation clinics in the Netherlands (Amersfoort, Amsterdam, The Hague, Leiden, Rotterdam, and Utrecht).
Participants
Premenopausal women
Citation impact
659
total citations
- FWCI
- 30.34
- Percentile
- 100%
- References
- 54
Citations per year
Authors
5Topics & keywords
Topics
Keywords
- Medicine
- Desogestrel
- Gestodene
- Odds ratio
- Drospirenone
- Progestogen
- Venous thrombosis
- Levonorgestrel
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.